The estimated Net Worth of Alice D. Schroeder is at least $569 Tisíc dollars as of 11 June 2021. Ms. Schroeder owns over 2,934 units of Natus Medical Inc stock worth over $399,376 and over the last 6 years she sold NTUS stock worth over $80,656. In addition, she makes $88,875 as Independent Director at Natus Medical Inc.
Sign up
Ms. Schroeder NTUS stock SEC Form 4 insiders trading
Alice has made over 1 trades of the Natus Medical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 2,934 units of NTUS stock worth $80,656 on 11 June 2021.
The largest trade she's ever made was selling 2,934 units of Natus Medical Inc stock on 11 June 2021 worth over $80,656. On average, Alice trades about 293 units every 0 days since 2018. As of 11 June 2021 she still owns at least 12,117 units of Natus Medical Inc stock.
You can see the complete history of Ms. Schroeder stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Alice Schroeder biography
Alice D. Schroeder serves as Independent Director of the Company. Alice Schroeder serves on the boards of Quorum Health Corporation and Prudential plc. She chairs the Quorum Health audit and compliance committee and serves on its nominating and governance committee. She also serves on the Prudential audit committee and on its risk committee. From February 2016 until December 2018, Ms. Schroeder chaired Bank of America Merrill Lynch International's ("BAMLI") audit committee and served on its governance committee. Ms. Schroeder was CEO and chair from 2014-2017 of WebTuner Corp., a Seattle-area software developer, though its turnaround and exit through sale in May 2017. Formerly, she was a Managing Director in the equities division of Morgan Stanley, leading the global insurance research team, and before that at PaineWebber and CIBC Oppenheimer, spending nearly two decades on Wall Street. She began her career as a CPA with Ernst & Young and spent two years as a project manager at the Financial Accounting Standards Board, overseeing the issuance of several key accounting standards for the insurance industry. M.B.A. Finance, University of Texas at Austin. B.B.A. Finance, University of Texas at Austin.
What is the salary of Alice Schroeder?
As the Independent Director of Natus Medical Inc, the total compensation of Alice Schroeder at Natus Medical Inc is $88,875. There are 13 executives at Natus Medical Inc getting paid more, with Jonathan Kennedy having the highest compensation of $3,335,550.
How old is Alice Schroeder?
Alice Schroeder is 63, she's been the Independent Director of Natus Medical Inc since 2019. There are 2 older and 15 younger executives at Natus Medical Inc. The oldest executive at Natus Medical Inc is Kenneth Ludlum, 66, who is the Independent Director.
What's Alice Schroeder's mailing address?
Alice's mailing address filed with the SEC is C/O NATUS MEDICAL INCORPORATED, 3150 PLEASANT VIEW ROAD, MIDDLETON, WI, 53562.
Insiders trading at Natus Medical Inc
Over the last 5 years, insiders at Natus Medical Inc have traded over $3,793,396 worth of Natus Medical Inc stock. The most active insiders traders include Dong Chune Christopher Chung, Joshua Levine a Jonathan Kennedy. On average, Natus Medical Inc executives and independent directors trade stock every 70 days with the average trade being worth of $543,972. The most recent stock trade was executed by Dong Chune Christopher Chung on 9 December 2021, trading 11,787 units of NTUS stock currently worth $243,755.
What does Natus Medical Inc do?
Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
What does Natus Medical Inc's logo look like?
Complete history of Ms. Schroeder stock trades at Quorum Health a Natus Medical Inc
Natus Medical Inc executives and stock owners
Natus Medical Inc executives and other stock owners filed with the SEC include:
-
Jonathan Kennedy,
President, Chief Executive Officer, Director -
B. Drew Davies,
Chief Financial Officer, Executive Vice President -
Austin Noll,
Executive Vice President and Chief Commercial Officer -
D. Christopher Chung,
Vice President - Quality, Regulatory Affairs and Chief Medical Officer -
Benjamin Drew Davies,
Exec. VP & CFO -
Austin F. Noll III,
Exec. VP & Chief Commercial Officer -
Dr. D. Christopher Chung M.D.,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Dr. D. Christopher Chung,
VP of Quality, Regulatory Affairs & Chief Medical Officer -
Barbara Paul,
Independent Chairman of the Board -
Kenneth Ludlum,
Independent Director -
Lisa Heine,
Independent Director -
Joshua Levine,
Independent Director -
Thomas Joseph Sullivan,
Pres, CEO & Director -
Alice Schroeder,
Independent Director -
Thomas Sullivan,
Independent Director -
Ilan Daskal,
Independent Director -
William Hill,
General Counsel -
Sean Langan,
Vice President of Global Operations -
Lisa Paul,
Vice President and Chief People Officer -
Douglas Balog,
VP, Gen. Counsel & Sec. -
Lisa Paul,
Chief People Officer & VP -
Ivan Pandiyan,
VP of Global R&D -
Seán Langan,
VP Global Operations -
Eric Guerin,
Director -
Bryant M Moore,
Director